<DOC>
	<DOCNO>NCT00130962</DOCNO>
	<brief_summary>Subjects painful primary post-operative intermetatarsal neuroma . Study drug placebo inject space contain neuroma . Subjects complete weekly assessment severity foot pain , brief pain inventory , amount pain medication take . Subjects see screen visit , treatment visit , two follow-up visit treatment . The last scheduled visit one month treatment . Some subject may follow monthly telephone interview ass level pain six-month period follow treatment .</brief_summary>
	<brief_title>ALGRX 4975 Treatment Patients With Morton 's Neuroma</brief_title>
	<detailed_description>Subjects painful primary post-operative intermetatarsal neuroma . Each subject randomly allocate receive either ALGRX 4975 placebo 1:1 ratio . Study drug placebo inject intermetatarsal space contain painful neuroma . Subjects complete weekly assessment Average Foot Pain Severity , 7 Interference Items BPI , number analgesic unit take . Some subject may follow monthly telephone interview ass level pain six-month period follow treatment . Plasma concentration assess pre-dose post dose 5 , 10 , 15 , 20 , 30 , 45 min 1 , 1.5 , 2 , 2.5 , 3 4 hour . Safety assess baseline study adverse event ( visit ) , vital sign ( Visit 2 pre post-injection Visit 3 early termination ) , laboratory assessment ( hematology , chemistry , urinalysis ) ECG ( Screening Visit 3 early termination ) . The injection site examine assessed 6-point scale erythema , edema , hemorrhage injection 1 , 2 4 hour injection . A pain injection NRS assess immediately post- injection 15 , 30 , 45 minute 1 , 2 , 3 , 4 hour study drug administration . A sensory examination foot perform injection 4 hour injection completion study . If subject injection pain , foot may wrap ice 20 minute , analgesic medication may provide .</detailed_description>
	<mesh_term>Neuroma</mesh_term>
	<criteria>Males female age &gt; 18 year Foot Xray rule alternative pathology , ultrasound magnetic resonance imaging ( MRI ) confirm presence neuroma within 6 month study entry Evidence either primary post surgical recurrence neuroma A score 4 great Average Foot Pain Severity Numeric Rating Scale ( NRS ) week prior randomization Failed conservative treatment wide shoe , orthotics , arch support , oral and/or inject analgesic Signed Informed Consent form approve Institutional Review Board For female subject : surgically sterile , least 2 year postmenopausal , use medically acceptable method ( determine Principal Investigator ) birth control ; childbearing potential pregnant ( document negative urine pregnancy test prior enrollment ) , plan get pregnant ( time course study ) , lactate Able understand requirement study , provide write informed consent , abide study restriction , agree return require assessment History clearly document allergic reaction lidocaine capsaicin . Prior participation ALGRX 4975 study . Presence medical condition instability , judgment Investigator , might adversely impact conduct study collection data , include chronic condition likely alter rate heal likely result safety complication unrelated study medication , diabetes mellitus extensive vascular disease Treatment neuroma narcotic analgesic Other painful foot pathology Active cutaneous , disease , anticipate site study drug injection Laboratory result normal range , opinion Investigator , clinically significant Drug alcohol abuse within past 2 year Require regular oral steroid medication , except stable use ( 6 month longer schedule dose ) mild moderate asthma Use investigational medication 30 day prior current study schedule receive agent participate current study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2005</verification_date>
	<keyword>Intermetatarsal neuroma</keyword>
	<keyword>Morton 's neuroma</keyword>
	<keyword>ALGRX 4975</keyword>
	<keyword>capsaicin</keyword>
</DOC>